NEW YORK — The morning after presenting an upbeat outlook to analysts in a gilded hall in the New York Stock Exchange building, Mick Farrell, the CEO of ResMed, looked refreshed, despite a post ...

On Thursday, JPMorgan reaffirmed its confidence in ResMed (NYSE:RMD), maintaining an Overweight rating with a steady price target of $240.00. The firm's outlook suggests that while sales growth ...

Valued at $35.3 billion by market cap, San Diego, California-based ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and cloud-based software applications for ...

The MyAir consumer app. [Image courtesy of ResMed] ResMed (NYSE: RMD) + today announced new patient-centric products designed to enhance therapy for sleep apnea patients. The new innovations from ...

After hours: October 18 at 5:16 PM EDT Loading Chart for RMD ...

2030 ambition to help more than 500 million people worldwide achieve their full health potential Showcases integration of intelligent products and solutions within the ResMed ecosystem ...

The AirTouch N30i mask. [Image courtesy of ResMed] ResMed (NYSE: RMD) + announced today that it launched its new AirTouch N30i continuous positive airway pressure (CPAP) mask. ResMed says it ...

On Thursday, JPMorgan (NYSE:JPM) reaffirmed its confidence in ResMed (NYSE:RMD), maintaining an Overweight rating with a steady price target of $240.00. The firm's outlook suggests that while sales ...